Diagnósticos da América : EBITDA up 14% and leverage down 20% as margin focus and restructuring drive improvements

About this update from Diagnosticos Da America S.a.

Operational efficiency and margin focus drove 14% EBITDA growth and 6% revenue increase year-over-year, while strict investment discipline and asset sales contributed to a 20% reduction in leverage. Ongoing restructuring and process optimization are expected to further improve margins and capital structure.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Diagnosticos Da America S.a.